Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 2 , ISSUE 1 ( January-June, 2012 ) > List of Articles


Role of Interferon-gamma and Interleukin-12 in the Immunopathogenesis of Hepatitis B Virus Infection

Nishat Afroz, Meher Rizvi, Mohd Azam, MR Ajmal, Abida Malik, Indu Shukla

Citation Information : Afroz N, Rizvi M, Azam M, Ajmal M, Malik A, Shukla I. Role of Interferon-gamma and Interleukin-12 in the Immunopathogenesis of Hepatitis B Virus Infection. Euroasian J Hepatogastroenterol 2012; 2 (1):5-9.

DOI: 10.5005/jp-journals-10018-1022

License: CC BY-NC 4.0

Published Online: 01-01-2011

Copyright Statement:  Copyright © 2012; The Author(s).


Objective: To study the role of interleukin (IL)-12 and interferon (IFN)- in immunopathogenesis of hepatitis B virus (HBV) infection. Materials and methods: One hundred and fifty-seven patients with hepatitis B were screened by serological and molecular markers for HBV. Serum IL-12 and IFN- levels were estimated. Results: Among patients with acute HBV (AHB), the mean levels of IFN- (52.35 pg/ml) and IL-12 (57.12 pg/ml) were significantly higher in patients with nonnecrotizing inflammation (NNI) compared to those in patients with necrotizing inflammation (NI) (32.17 pg/ml and 42 pg/ml for IFN- and IL- 12 respectively). In chronic HBV (CHB) with NI, IFN- levels were much higher than the same in AHB. However, no significant difference was found in IL-12 levels. IL-12 levels (25.76 pg/ml) were lower in NNI of CHB patients, while the levels of IL-12 were comparable between NI patients with AHB and CHB. Both IFN- and IL-12 were higher in hepatitis B e-antigen (HBeAg)-negative patients than HBeAg-positive patients. . Conclusion: Both IFN- and IL-12 appear to play a role in AHB and HBeAg negativity, however, further study will be required to get their precise role.

PDF Share
  1. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature (Lond.) 1985;317:489-95
  2. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991;174:1565-70
  3. HLA-A31- and HLAAw68- restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 1993;177:751-62
  4. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 1991;1(88):10445-49
  5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993;150:4659-71
  6. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995;181:1047-58
  7. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60
  8. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients. Hepatology 1995; 21:650-55
  9. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997;25:1022-27
  10. Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms. Hepatology 2000;32:1117-24
  11. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus. Hepatology 1995;22:1040-49
  12. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 1992;89:87-96
  13. Proliferative response of CD41 T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology 1995;22:61-68
  14. Lymphocyte responses and cytokines. Cell 1994;76:241-51
  15. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-76
  16. Failure to detect circulating interferon during acute viral hepatitis. J Infect Dis 1984;149:831
  17. Absence of detectable serum interferon in acute and chronic viral hepatitis. Hepatology 1986;6:645-47
  18. Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection. Dig Dis Sci 1995;40:2107-12
  19. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 2003;28:93-103
  20. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 1997;99:3025-33
  21. Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994;152:1253-64
  22. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon- production by T helper 1 cells. Eur J Immunol 1996; 26: 659-62
  23. Interleukin-12 induces the differentiation of major histocompatibility complex class Iprimed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc Natl Acad Sci USA 1994;91:12659
  24. Chronic viral hepatitis and the human genome. Hepatology 2000;31:819-27
  25. Type 1 IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 1998;160:4298-302
  26. Do Liver IL- 12 levels predict sustained response to IFN-alpha therapy in children with chronic hepatitis B? J Interferon Cytokine Res 2010;30:433-38.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.